Healthequity, INC Form 4 insider transactions

EVP and Chief Technology Officer of HealthEquity, Elimelech Rosner, reports disposing of common stock to cover tax obligations.

Delano Ladd, EVP, GC & Corporate Secretary of HealthEquity, Inc., reported the disposal of common stock to cover tax obligations.

HealthEquity's CEO, Jon Kessler, executed multiple sales of common stock under a pre-arranged Rule 10b5-1 trading plan.

Stephen Neeleman, HealthEquity's Founder and Vice Chairman, executed stock option exercises and sales on June 6th and 7th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reports transactions involving the acquisition and disposal of common stock and stock options under a pre-arranged Rule 10b5-1 trading plan.

Stephen Neeleman, a Director and Officer of HealthEquity, Inc., exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Elimelech Rosner, EVP and Chief Technology Officer of HealthEquity, Inc., reported the disposal of 3,209 shares of common stock on April 3, 2024.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reports disposition of shares to cover tax obligations related to equity awards.

Delano Ladd, EVP, GC & Corporate Secretary of HealthEquity, Inc., disposed of 1,684 shares of common stock on April 3, 2024, to cover tax obligations.

Jon Kessler, CEO of HealthEquity, reports the disposition of shares to cover tax obligations and holdings of stock options.

Delano Ladd, EVP, GC & Corporate Secretary of HealthEquity, Inc., reported the disposal of common stock to cover tax obligations.

Stephen Neeleman, a Director and Founder/Vice Chairman at Healthequity Inc., reported disposing of shares to cover tax obligations and holding significant direct and indirect ownership.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, reports acquisition and disposal of common stock and derivative securities.

HealthEquity's CEO, Jon Kessler, reports the vesting of restricted stock units and adjustments to his holdings of common stock and stock options.

Delano Ladd, EVP, GC & Corporate Secretary of HealthEquity, Inc., reports the acquisition of restricted stock units.

Elimelech Rosner, EVP and Chief Technology Officer of HealthEquity, Inc., reports the acquisition and disposal of common stock and restricted stock units.

James Lucania, EVP & CFO of HealthEquity, Inc., filed a Form 4 disclosing the acquisition and disposal of common stock.

HealthEquity's EVP and Chief Security Officer, Slim Aissi, reports the acquisition and disposition of common stock related to restricted stock units.

Evelyn S. Dilsaver, a director at HealthEquity, Inc., exercised stock options and sold shares of common stock on March 26, 2024.

HealthEquity's CEO, Jon Kessler, exercised stock options and sold a portion of the acquired shares, while also reporting indirect ownership through GKF, LLC.

Delano Ladd, EVP, GC & Corporate Secretary of HealthEquity, Inc., sold 2,558 shares of common stock at $82.59 per share on March 1, 2024, under a pre-arranged 10b5-1 trading plan.